Skip to main content
S&P 5007,722.72+0.73%DOW51,176.96+0.49%NASDAQ27,190.86+1.19%BTC$84,654.00-0.13%ETH$2,677.39-1.09%GOLD$4,172.10-0.72%OIL$91.26-1.73%
Smart Investors Daily
SID Premium
SX

NASDAQ · SXTC

China SXT Pharmaceuticals, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$2.41

Down-$0.55 (-18.58%)

Updated Oct 5, 2026, 5:08 AM

SID Score

3.5/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
157.8M
P/E ratio
-1.01
Dividend yield
0.00%
52-week range
$0.05 – $1,046.99
Volume
779.92K
Avg. volume
136.47K

Price performance · SXTC

SXTC price history

1M range · 19 trading sessions · Daily adjusted prices

Prices through Oct 2, 2026

SXTC closed at $2.41 after 19 trading sessions, up 7.59% for the selected period.

Last close
$2.41
Period change
+7.59%
Period low
$1.93
Period high
$3.01
Daily close
View OHLC price history
SXTC OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 2, 2026$3.00$3.09$1.941$2.41779.92K
Oct 1, 2026$3.02$3.27$2.91$2.96299.67K
Sep 30, 2026$2.79$3.10$2.76$3.01192.47K
Sep 29, 2026$2.49$3.05$2.23$2.81872.79K
Sep 28, 2026$2.59$2.74$2.52$2.5242.2K
Sep 25, 2026$2.4811$2.60$2.48$2.5718.17K
Sep 24, 2026$2.53$2.60$2.48$2.5541.79K
Sep 23, 2026$2.47$2.68$2.35$2.5175.24K
Sep 22, 2026$2.31$2.49$2.30$2.4766.45K
Sep 21, 2026$2.35$2.4081$2.2543$2.3860.57K
Sep 18, 2026$2.39$2.48$2.31$2.4055.68K
Sep 17, 2026$2.34$2.52$2.2231$2.435204.17K
Sep 16, 2026$2.335$2.3996$2.13$2.19115.23K
Sep 15, 2026$2.53$2.56$2.33$2.36123.01K
Sep 14, 2026$2.47$2.7184$2.2809$2.66310.78K
Sep 11, 2026$2.24$3.00$2.12$2.5614.16M
Sep 10, 2026$2.15$2.17$1.78$1.9399.03K
Sep 9, 2026$2.30$2.3863$2.14$2.1451.61K
Sep 8, 2026$2.33$2.35$2.21$2.2436.92K

Latest SXTC news

The latest Smart Investors Daily articles mentioning SXTC.

Stock researchCompany · Overview

SXTC research

Overview

Company profile and research snapshot.

Company profile

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jan 15, 2026

CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN

TAIZHOU, China, Jan. 15, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today announced as part of its Artificial Intelligence (AI) Insight

Yahoo · Jan 13, 2026

Univest Securities, LLC Announces Closing of $10 Million Registered Direct Offering for its Client China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC)

New York, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the “Offering”) of approximately $10 million for its client China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (the “Company” or “China SXT”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By